Unity Biotech (UBX) has disclosed a new risk, in the Regulation category.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Unity Biotech faces significant risks due to potential noncompliance with regulatory standards, which could severely impact its operational outcomes. The company is vulnerable to misconduct by employees and contractors, which may include illegal activities violating FDA and other regulatory laws. Such misconduct could lead to serious legal and financial repercussions, including fines, reputational damage, and exclusion from key healthcare programs. The inability to detect and prevent these activities might result in substantial penalties and harm to Unity Biotech’s business operations and financial performance.
The average UBX stock price target is $8.00, implying 561.16% upside potential.
To learn more about Unity Biotech’s risk factors, click here.
